MedTrace Logo

Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies

NCT06376604 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-04-19

No results posted yet for this study

Summary

This study evaluates how lifestyle modifications that may be made to manage chemotherapy side effects in patients with gynecologic malignancies.

Conditions

  • Cancer, Ovarian
  • Chemotherapy Effect
  • Calorie Deficiency
  • Fasting, Intermittent

Interventions

OTHER

Fasting Mimicking Diet

Subject will consume 6 cycles of 5-day fasting mimicking diet: 3 days prior to, the day of, and 1 day following chemotherapy treatments.

DRUG

Chemotherapy

6 cycles of standard chemotherapy for the gynecologic malignancy.

Sponsors & Collaborators

  • University of Tennessee Medical Center

    collaborator OTHER

  • L-Nutra Inc

    lead INDUSTRY

Principal Investigators

  • Jonathan D Boone · The University of Tennessee Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-08
Primary Completion
2025-09-01
Completion
2025-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06376604 on ClinicalTrials.gov